Clinical Translation of Nanomedicine

ADVERTISEMENT RETURN TO ISSUEPREVReviewClinical Translation of NanomedicineYuanzeng Min, Joseph M. Caster, Michael J. Eblan, and Andrew Z. Wang*View Author Information Laboratory of Nano- and Translational Medicine, Carolina Institute of Nanomedicine, Department of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina—Chapel Hill, Chapel Hill, North Carolina 27599, United States*E-mail: [email protected]. Website: http://www.med.unc.edu/radonc/Wang.Cite this: Chem. Rev. 2015, 115, 19, 11147–11190Publication Date (Web):June 19, 2015Publication History Received24 February 2015Published online19 June 2015Published inissue 14 October 2015https://pubs.acs.org/doi/10.1021/acs.chemrev.5b00116https://doi.org/10.1021/acs.chemrev.5b00116review-articleACS PublicationsCopyright © 2015 American Chemical SocietyRequest reuse permissionsArticle Views10700Altmetric-Citations611LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Antineoplastic agents,Cancer,Cancer therapy,Pharmaceuticals,Toxicity Get e-Alerts